11.02.22 -- Trends In DCT Remote Monitoring For Medication Adherence

Duchenne muscular dystrophy (DMD), the most common form of muscular dystrophy, is an X-linked recessive disease that affects approximately one in 5,000 live male births and has no curative therapy. This article discusses the limitations of classical therapeutic endpoints and how to consider novel strategies.

This paper examines the requirements for effectively and successfully conducting hematologic oncology clinical trials.

The industry has been forced to change, adapt, and innovate in unexpected ways, compressing digital transformation roadmaps for how clinical trials are planned and conducted. But can we maintain and continue this rapid transformation?

Plain language summaries (PLS) of clinical trial results are a critical tool in medical communication to help disseminate summarized, easy-to-digest research information to general audiences. Here are key insights into developing an effective PLS. 

Marken provides a best-in-class quality management system, a global GMP depot network, direct-to/from-patient, home healthcare nursing services, and industry-leading expertise all under one single-source provider.

We surveyed sites around the world! Hear what they have to say about how ClinCard's global capabilities have helped improve their trials.

Partner with a company that knows drug development, including trial design, clinical development plans, protocol writing, working with regulators,  and medical oversight of clinical trials.

With the implementation of real-time remote monitoring technology, pharmas will be able to do more remote studies that will allow clinical trial patients to visit sites less frequently. This will remove the burden on patients and improve patient recruitment and retention. This article focuses on the patient medication adherence market.

In recent years, the direct-to-patient model, which brings medical procedures to a patient’s home, has emerged as a solution for sponsors to increase patient recruitment and retention in clinical trials.

Learn how IRT is used to support direct-to-patient delivery in this hybrid trial case study presentation. 

In this case study, discover the complexity that decentralized clinical trials (DCTs) may add to patient enrollment and retention due to the lack of interaction between patient and trial personnel.

We understand how challenging it is to adopt a novel approach to drug development. Pivoting to virtual clinical trials is no exception.

Discover how PHILIPS makes at-home clinical trials easy with the DCT+ app.